In conclusion, in the overall TRANsIBCCS prospective cohort of BRCA1 and BRCA2 PV carriers who were ascertained through genetic clinics, primarily on the basis of cancer FH, the multifactorial BOADICEA provided good discriminatory ability and was calibrated in predicting 5-year risks within different risk categories. This evidence concerns the gene BRCA1 and cancer.